Atlas Trials

Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study

Clinical trial NCT07084246 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07084246
Sponsor
GC Biopharma Corp
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Hypertension, Dyslipidemia
Start date
2023-06-07
Primary completion
2025-12-01
Enrollment
1563

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.